Bank of New York Mellon’s Cellectar Biosciences CLRB Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q2 | – | Sell |
-401
| Closed | -$17.2K | – | 4386 |
|
2023
Q1 | $17.2K | Hold |
401
| – | – | ﹤0.01% | 4318 |
|
2022
Q4 | $20.6K | Sell |
401
-3
| -0.7% | -$154 | ﹤0.01% | 4351 |
|
2022
Q3 | $41K | Hold |
404
| – | – | ﹤0.01% | 4350 |
|
2022
Q2 | $49K | Sell |
404
-2
| -0.5% | -$243 | ﹤0.01% | 4343 |
|
2022
Q1 | $84K | Hold |
406
| – | – | ﹤0.01% | 4435 |
|
2021
Q4 | $81K | Hold |
406
| – | – | ﹤0.01% | 4435 |
|
2021
Q3 | $113K | Buy |
406
+311
| +327% | +$86.6K | ﹤0.01% | 4301 |
|
2021
Q2 | $34K | Hold |
95
| – | – | ﹤0.01% | 4359 |
|
2021
Q1 | $46K | Sell |
95
-11
| -10% | -$5.33K | ﹤0.01% | 4270 |
|
2020
Q4 | $66K | Buy |
+106
| New | +$66K | ﹤0.01% | 4124 |
|